OscarLLopezMD
Neurology • Pittsburgh, PAProfessor, Neurology, University of Pittsburgh School of Medicine
Are you Dr. Lopez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 36 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3459 5th Ave
4 West Muh
Pittsburgh, PA 15213Phone+1 412-692-2700Fax+1 412-692-4907
Summary
- Dr. Oscar Lopez, MD is a neurologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with UPMC Presbyterian Shadyside and is a Professor at University of Pittsburgh School of Medicine.
Education & Training
Universidad Nacional de La Plata Faculty of MedicineClass of 1980
Certifications & Licensure
PA State Medical License 1991 - 2026
Clinical Trials
- Enhancing Rehabilitation After Stroke Start of enrollment: 2009 Mar 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Publications & Presentations
PubMed
- Where Do Plasma Biomarkers fit in With Current Alzheimer's Disease Detection?Ariel Gildengers, Andrea M Weinstein, Swathi Gujral, Xuemei Zeng, Jihui L Diaz
The American Journal of Geriatric Psychiatry. 2025-04-01 - Circulating non-esterified fatty acids, risk of dementia and cognitive decline: The cardiovascular health study and multi-ethnic study of atherosclerosis.Kristine F Moseholm, Majken K Jensen, Petra Buzkova, Sarah A Aroner, Annette L Fitzpatrick
Neurobiology of Aging. 2025-04-01 - Sex-stratified genome-wide meta-analysis identifies novel loci for cognitive decline in older adults.Vibha Acharya, Kang-Hsien Fan, Beth E Snitz, Mary Ganguli, Steven T DeKosky
Alzheimer's & Dementia. 2025-03-01
Press Mentions
Scientists Validate New Lab Test Platform for Alzheimer’s Blood BiomarkersOctober 10th, 2024- Pitt Scientists Validate New Lab Test Platform for Blood Biomarkers of Alzheimer's DiseaseOctober 9th, 2024
- Department of Aging Shares Alzheimer’s Prevention and Caregiving ModelsFebruary 13th, 2022
- Join now to see all
Grant Support
- Amyloid Depostion, Vascular Disease And Clinical Progression Of ADNational Institute On Aging2010–2012
- Administrative CoreNational Institute On Aging2010–2012
- Alzheimer'S Disease Research CenterNational Institute On Aging2008–2012
- Cardiovascular Health Study (CHS)National Center For Research Resources2011
- Predictors Of Alheimers Disease In Mild Cognitive ImpairmentNational Institute On Aging2008–2011
- Chs-Cognition StudyNational Center For Research Resources2008–2011
- Ginkgo Biloba Prevention Trial In Older IndividualsNational Center For Complementary &Alternative Medicine2008–2009
- Predictors Of Alzheimers Disease In Mild Cognitive ImpairmentNational Institute On Aging2007
- Alzheimers Disease In Mild Cognitive ImpairmentNational Institute On Aging2002–2006
Other Languages
- Spanish
